Susan Rowinski, MSE
President and CEO
Susan has 26 years of combined operating and consulting experience in developing and selling new medical technologies. Her combined experience spans the entire company life cycle and includes raising venture capital, managing strategic corporate partners, securing payer approvals, overseeing three worldwide introductions, and sales responsibility for five western U.S. states.
Prior to starting Rowinski Group LLC in 2004, Susan held operating positions with increasing responsibility; Vice President, Marketing (PharmaSonics; Sunnyvale, California USA), Director of Marketing (Cardiometrics; Mountain View, California USA), Global Marketing Manager (Medtronic Vascular; San Diego, California USA), Product Manager (Quinton Instrument Company; Seattle, Washington USA), and Echocardiography Sales Representative (Advanced Technology Labs (ATL); Seattle, Washington USA).
Ms. Rowinski has been an advisor to boards and accelerators. She served for six years (2013-2018) as a board member on the Purdue University Weldon Biomedical Advisory Board. From 2008-2020 Susan was an advisor on reimbursement strategy and planning for the National Institutes of Health (NIH) Commercialization Accelerator Program and the California-based accelerators, the San Jose BioCenter and the Astia Accelerator.
Susan holds a Master of Science in Engineering from the University of Washington (Seattle, Washington) and a Bachelor of Science in Health Physics from Purdue University (West Lafayette, Indiana). Susan is a current member of the teaching faculty for the University of Michigan Master of Engineering program (MSE) and for the Georgia Institute of Technology Master of BioMedical Innovation and Development (MBID).
Ms. Rowinski is a speaker at global medical technology conferences. Her presentations focus on the critical role reimbursement plays in the successful launch and commercial adoption of new medical devices, digital health platforms and diagnostics.